Psyence Biomedical (PBM) Competitors $3.24 +0.04 (+1.25%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$3.24 +0.00 (+0.15%) As of 08/22/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PBM vs. NAII, NNVC, PASG, QTTB, RLMD, LSTA, CING, BCAB, ELEV, and SNGXShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include Natural Alternatives International (NAII), NanoViricides (NNVC), Passage Bio (PASG), Q32 Bio (QTTB), Relmada Therapeutics (RLMD), Lisata Therapeutics (LSTA), Cingulate (CING), BioAtla (BCAB), Elevation Oncology (ELEV), and Soligenix (SNGX). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. Its Competitors Natural Alternatives International NanoViricides Passage Bio Q32 Bio Relmada Therapeutics Lisata Therapeutics Cingulate BioAtla Elevation Oncology Soligenix Psyence Biomedical (NASDAQ:PBM) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation. Which has more volatility & risk, PBM or NAII? Psyence Biomedical has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500. Comparatively, Natural Alternatives International has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Do institutionals & insiders hold more shares of PBM or NAII? 77.4% of Psyence Biomedical shares are held by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are held by institutional investors. 3.6% of Psyence Biomedical shares are held by insiders. Comparatively, 20.9% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer PBM or NAII? In the previous week, Psyence Biomedical's average media sentiment score of 0.00 equaled Natural Alternatives International'saverage media sentiment score. Company Overall Sentiment Psyence Biomedical Neutral Natural Alternatives International Neutral Is PBM or NAII more profitable? Psyence Biomedical has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.56%. Psyence Biomedical's return on equity of 0.00% beat Natural Alternatives International's return on equity.Company Net Margins Return on Equity Return on Assets Psyence BiomedicalN/A N/A N/A Natural Alternatives International -6.56%-10.34%-5.19% Which has stronger valuation and earnings, PBM or NAII? Psyence Biomedical has higher earnings, but lower revenue than Natural Alternatives International. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPsyence BiomedicalN/AN/A$1.01MN/AN/ANatural Alternatives International$113.80M0.22-$7.22M-$1.39-2.86 SummaryPsyence Biomedical beats Natural Alternatives International on 5 of the 8 factors compared between the two stocks. Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PBM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBM vs. The Competition Export to ExcelMetricPsyence BiomedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.05M$3.12B$5.83B$9.78BDividend YieldN/A2.23%4.40%4.05%P/E RatioN/A21.0031.3026.05Price / SalesN/A357.30455.25117.77Price / Cash1.8144.5038.0259.36Price / Book0.278.129.536.60Net Income$1.01M-$54.72M$3.26B$265.65M7 Day Performance-0.92%2.62%2.14%2.01%1 Month Performance-60.77%2.68%2.81%-0.33%1 Year Performance-98.93%10.93%30.70%19.04% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMPsyence Biomedical1.168 of 5 stars$3.24+1.3%N/A-99.0%$6.05MN/A0.00N/ANAIINatural Alternatives InternationalN/A$3.85-0.3%N/A-28.5%$23.85M$113.80M-2.77290Gap DownNNVCNanoViricides0.7239 of 5 stars$1.44-5.9%N/A-21.7%$23.14MN/A-2.0020PASGPassage Bio3.792 of 5 stars$6.93-4.0%$91.75+1,224.0%-47.6%$22.95MN/A-0.38130QTTBQ32 Bio2.5583 of 5 stars$1.81-11.3%$12.17+572.2%-95.0%$22.08MN/A-0.4239News CoverageShort Interest ↓RLMDRelmada Therapeutics4.3257 of 5 stars$0.62-6.5%$5.00+705.0%-77.6%$22.04MN/A-0.2810LSTALisata Therapeutics2.3005 of 5 stars$2.54+1.3%$23.50+824.5%-8.5%$21.98M$1M-1.1430Analyst ForecastAnalyst RevisionGap DownCINGCingulate2.4467 of 5 stars$3.76-9.6%$26.00+591.5%-63.1%$21.90MN/A-0.4420Trending NewsEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionBCABBioAtla2.2866 of 5 stars$0.37-4.8%$5.00+1,251.0%-80.2%$21.73M$11M-0.3460Gap UpELEVElevation Oncology1.3513 of 5 stars$0.37flat$2.62+616.9%N/A$21.62MN/A-0.4540SNGXSoligenix2.1439 of 5 stars$3.70-25.4%$6.00+62.2%-20.3%$21.26M$120K-0.9720Gap Down Related Companies and Tools Related Companies Natural Alternatives International Alternatives NanoViricides Alternatives Passage Bio Alternatives Q32 Bio Alternatives Relmada Therapeutics Alternatives Lisata Therapeutics Alternatives Cingulate Alternatives BioAtla Alternatives Elevation Oncology Alternatives Soligenix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PBM) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access